Abstract
Brucellosis is still endemic in many countries in the world, however, having a significantly higher incidence in developing countries. As consequence of travel, risk for children from non-endemic areas would be considerable when visiting developing countries. Then, the purpose of this review is to provide, after a bibliographical search, an update on the main aspects of this disease in the traveler children. For the general practitioner, but particularly for travel medicine practitioner and pediatricians, these clinicoepidemiological considerations should be taken in mind in the differential diagnosis when assessing children returning from travel to brucellosis endemic areas.
Keywords: Brucellosis, children, epidemiology, travel, travel medicine.
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Drug Safety
Current Drug Targets
Current Medicinal Chemistry
Current Pharmaceutical Biotechnology
Central Nervous System Agents in Medicinal Chemistry
Infectious Disorders - Drug Targets
Letters in Drug Design & Discovery
Current HIV Research
Related Books
Marine Biopharmaceuticals: Scope and Prospects
COVID 19 – Monitoring with IoT Devices
Frontiers in Clinical Drug Research: Anti-Infectives
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents
Recent Trends and The Future of Antimicrobial Agents - Part 2
COVID-19: Origin, Impact and Management (Part 2)
Frontiers in Anti-Infective Drug Discovery
COVID-19: Origin, Impact and Management, Part 1
Toll-Like Receptors in Vector-borne Diseases
24